Accelerate Diagnostics, Inc - Common Stock, $0.001 par value per share (AXDXQ)

CUSIP: 00430H201

Q2 2024 13F Holders as of 30 Jun 2024

Holder snapshot 7 signals
Share change
-348,462
Put/Call ratio
0.51%
SEC-reported price per share
$1.17
Number of holders
39
Value change
-$378,312
Number of buys
10
Open additional details 1 more signal available
Number of sells
15
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
25,187,879

Security key

00430H201

Report period

Q2 2024

Institutions

39

Top holders

10

Ownership snapshot

Top reported holders of AXDXQ - Accelerate Diagnostics, Inc - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Matthew W. Strobeck
Disclosed value leader
Matthew W. Strobeck
Comparable rows
0/15
Latest evidence
31 May 2024
3/4/5 13F Highest disclosed value: $2,467,531 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Matthew W. Strobeck has the largest disclosed position value at $2.47M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Matthew W. Strobeck's linked filing trail.
Disclosed position value Top 5
Matthew W. Strobeck $2.47M
ARMISTICE CAPITAL, LLC $1.83M
GRIFFIN ASSET MANAGEMENT, INC. $1.34M
Mark S. Black $1.1M
Marran H. Ogilvie $1.1M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Matthew W. Strobeck
3/4/5
Director
—
mixed-class rows
$2,467,531
662,080 shares
mixed-class rows
— 23 Jan 2024
ARMISTICE CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$1,827,540
1,846,000 shares
— 31 Mar 2024
GRIFFIN ASSET MANAGEMENT, INC.
13F
Company
13F
—
denominator unverified
$1,340,711
1,354,254 shares
— 31 Mar 2024
Mark S. Black
3/4/5
Director
—
mixed-class rows
$1,098,403
303,509 shares
mixed-class rows
— 20 May 2024
Marran H. Ogilvie
3/4/5
Director
—
mixed-class rows
$1,098,403
303,509 shares
mixed-class rows
— 20 May 2024
Jennifer Regan
3/4/5
Director
—
mixed-class rows
$1,067,524
268,420 shares
mixed-class rows
— 29 May 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
39
Shares
3,927,856
Rows available
39
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q3 2025 Across Filers

Q3 2025 holders
0
Q2 2024 holders
39
Holder diff
39
Investor Q3 2025 Shares Q2 2024 Shares Share Diff Share Chg % Q3 2025 value Q2 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .